S
RXST icon

SignatureFD’s RxSight RXST Stock Holding History

SignatureFD’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-884
Closed -$5.45K – 3613
2026
Q1 		$5.45K Sell
884
-2,666
-75% -$22.1K ﹤0.01% 2751
2025
Q4 		$37K Sell
3,550
-18
-0.5% -$181 ﹤0.01% 1818
2025
Q3 		$32.1K Buy
3,568
+2,736
+329% +$24K ﹤0.01% 1881
2025
Q2 		$10.8K Buy
832
+741
+814% +$11.1K ﹤0.01% 2321
2025
Q1 		$2.3K Buy
91
+16
+21% +$475 ﹤0.01% 2838
2024
Q4 		$2.58K Hold
75
– – ﹤0.01% 2795
2024
Q3 		$3.71K Hold
75
– – ﹤0.01% 2656
2024
Q2 		$4.51K Hold
75
– – ﹤0.01% 2550
2024
Q1 		$3.87K Hold
75
– – ﹤0.01% 2617
2023
Q4 		$3.02K Hold
75
– – ﹤0.01% 2656
2023
Q3 		$2.09K Buy
+75
New +$2.24K ﹤0.01% 2759

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SignatureFD's RXST Position: Q2 2026 in Review

SignatureFD sold out of RxSight (RXST) in Q2 2026, closing a stake of 884 shares — an estimated $5.45K sold.

SignatureFD first reported a position in RXST in Q3 2023 and held it in 11 quarters. The position peaked at $37K in Q4 2025. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • SignatureFD reported no remaining RxSight position as of Q2 2026 after selling out during the quarter.
  • SignatureFD sold 884 RxSight shares in Q2 2026, an estimated $5.45K.
  • SignatureFD first reported a position in RxSight in Q3 2023 and held it in 11 quarters.
  • SignatureFD's RxSight position peaked at $37K in Q4 2025.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.